CPNE8 Antikörper (AA 30-110)
Kurzübersicht für CPNE8 Antikörper (AA 30-110) (ABIN7219744)
Target
Alle CPNE8 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 30-110
-
Verwendungszweck
- Copine 8 Polyclonal Antibody
-
Spezifität
- Copine 8 Polyclonal Antibody detects endogenous levels of Copine 8 protein.
-
Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen
-
Immunogen
- Synthesized peptide derived from the N-terminal region of human Copine 8 at AA range: 30-110
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB (1:500-1:2000), IHC-P (1:100-1:300), ELISA (1:40000). Not yet tested in other applications.
-
Kommentare
-
Primary Antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- PBS containing 50 % Glycerol, 0.5 % BSA and 0.02 % Sodium Azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
-
-
- CPNE8 (Copine VIII (CPNE8))
-
Andere Bezeichnung
- Copine 8
-
Hintergrund
- Rabbit Anti-Copine 8 Polyclonal Antibody,CPNE8, Copine-8, Copine VIII,Calcium-dependent membrane-binding proteins may regulate molecular events at the interface of the cell membrane and cytoplasm. CPNE8 is one of several genes that encode a calcium-dependent protein containing two N-terminal type II C2 domains and an integrin A domain-like sequence in the C-terminus.,Copine-8
-
Molekulargewicht
- observerd band 65kDa
-
Gen-ID
- 144402
-
UniProt
- Q86YQ8
Target
-